ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.19
0.00%
US Tech 100
21,141.60
0.47%
S&P 500
6,013.13
-1.71%
US Dollar vs CAD
1.42162
-0.14%
Bitcoin
95,726.75
-0.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Akari Therapeutics PLC (AKTX)

  7. Akari Therapeutics PLC (AKTX) News

AKTX

Akari Therapeutics (AKTX)

Akari Therapeutics PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AKTX
DateTimeSourceHeadlineSymbolCompany
02/19/20258:00AMGlobeNewswire Inc.Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceNASDAQ:AKTXAkari Therapeutics PLC
02/14/20254:00PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AKTXAkari Therapeutics PLC
02/07/20253:30PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AKTXAkari Therapeutics PLC
02/03/20257:00AMGlobeNewswire Inc.Akari Therapeutics Joins Webull Corporate Connect Service PlatformNASDAQ:AKTXAkari Therapeutics PLC
01/13/20257:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
01/13/20257:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
01/13/20257:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKTXAkari Therapeutics PLC
01/10/20254:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
01/07/20253:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/30/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/30/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/27/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/27/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/26/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/26/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/26/20243:30PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/26/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/20/20243:30PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/18/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKTXAkari Therapeutics PLC
12/18/20247:51AMGlobeNewswire Inc.Akari Therapeutics Announces Key Leadership AppointmentsNASDAQ:AKTXAkari Therapeutics PLC
12/16/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKTXAkari Therapeutics PLC
12/16/20248:05AMGlobeNewswire Inc.Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial OfficerNASDAQ:AKTXAkari Therapeutics PLC
12/06/20243:00PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AKTXAkari Therapeutics PLC
12/03/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
12/03/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
11/22/20243:30PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
11/22/20243:30PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
11/19/20243:48PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AKTXAkari Therapeutics PLC
11/18/20247:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
11/15/20243:05PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:AKTXAkari Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:AKTX

Your Recent History

COIN
XRPUSD
Ripple
USOTC
HIRU
Hiru (PK)
NASDAQ
COOP
Mr Cooper
USOTC
AZRH
Azure (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
RDGL
Vivos (QB)
USOTC
RNVA
Rennova Health (CE)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NBRI
North Bay Resources (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads